Evropska unija - slovenščina - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirusi za sistemsko uporabo - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Evropska unija - slovenščina - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastična sredstva - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Evropska unija - slovenščina - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - karcinom, pljučni pljuč - antineoplastična sredstva - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastična sredstva - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - imunosupresivi - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

Evropska unija - slovenščina - EMA (European Medicines Agency)

proveca pharma limited - enalapril (maleate) - odpoved srca - sredstva, ki delujejo na sistem renin-angiotenzin - treatment of heart failure.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - amlodipin; perindopril - tableta - amlodipin 5 mg / 1 tableta  perindopril3,34 mg / 1 tableta; perindopril 3,34 mg / 1 tableta - perindopril in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - amlodipin; perindopril - tableta - amlodipin 10 mg / 1 tableta  perindopril6,68 mg / 1 tableta; perindopril 6,68 mg / 1 tableta - perindopril in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - amlodipin; perindopril - tableta - amlodipin 10 mg / 1 tableta  perindopril3,34 mg / 1 tableta; perindopril 3,34 mg / 1 tableta - perindopril in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - amlodipin; perindopril - tableta - amlodipin 5 mg / 1 tableta  perindopril6,68 mg / 1 tableta; perindopril 6,68 mg / 1 tableta - perindopril in amlodipin